179 results
Page 2 of 9
6-K
EX-99.1
c5eb oc9odidw
2 May 23
Current report (foreign)
4:15pm
6-K
EX-99.1
e4m3wo2st5pl9
23 Dec 22
Galapagos announces changes to Executive Committee
6:05am
6-K
EX-99.1
amtq6clt14t
13 Dec 22
Galapagos and CellPoint presented encouraging initial data at ASH 2022 for GLPG5101, a CD19 CAR-T candidate manufactured at point-of-care
7:49am
6-K
EX-99.1
yxnpe ch5
14 Nov 22
Current report (foreign)
6:05am
6-K
EX-99.1
b5m06aw7gm98fb e4
9 Nov 22
Current report (foreign)
4:05pm
6-K
EX-99.1
kc6q ceokl
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.2
vfsloy18
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.1
qhz4f0
4 Nov 22
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022
4:57pm
6-K
EX-99.1
8l0x7 83f2
6 Oct 22
Current report (foreign)
5:11pm
6-K
EX-99.1
mk5w6xiecf7w
3 Oct 22
Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies
6:02pm
6-K
EX-99.1
b3e9tp6s8n
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.2
9orj0gi g51z2ov2up
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.1
qwepuan2o yx
31 May 22
Current report (foreign)
1:39pm
6-K
EX-99.1
nshtpi85arhd
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.2
762eg6itup2ufo161ccw
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.3
y3l86e5l91 pqvg8g
11 Apr 22
Current report (foreign)
5:14pm
6-K
EX-99.1
jms pqizmn
28 Mar 22
Jyseleca® approved in Japan for ulcerative colitis
1:50pm
6-K
EX-99.1
bmndkyul s5kcfaud
24 Feb 22
Galapagos 2021 results set stage for future growth
5:19pm
6-K
EX-99.1
am97y0jb1j
7 Feb 22
Current report (foreign)
2:40pm